ORIFARM PI A/S: Financial statements 2025
CVR: 27347177
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ORIFARM PI A/S (CVR 27347177) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -446,000 and a net result of DKK 298,665,000 compared with DKK 320,939,000 the year before. Equity in the 2025 report amounted to DKK 1,391,995,000. The solvency ratio was 87.8%.
- Gross Profit
- DKK -446,000
- Profit/Loss
- DKK 298,665,000
- Equity
- DKK 1,391,995,000
- Total Assets
- DKK 1,584,917,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -446K | 298.7M | 1.4B | 0 |
| 2024 | - | -58K | 320.9M | 1.2B | 0 |
| 2023 | - | -95K | 253.4M | 940.7M | - |
| 2022 | - | -73K | 182.9M | 687.4M | 0 |
| 2021 | - | -76K | 206M | 760M | 0 |
Official annual report
How creditworthy is ORIFARM PI A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of October 20, 2025, Nicki Lund Kristensen has joined the board of directors of ORIFARM PI A/S.
ORIFARM PI A/S has published its annual report for 2024. Gross profit came to DKK -58,000, and the net result was DKK 320,939,000.
As of March 17, 2025, Mads Fink Eriksen has joined the board of directors of ORIFARM PI A/S.
As of March 17, 2025, Erik Sandberg has left the board of directors of ORIFARM PI A/S.
About ORIFARM PI A/S
ORIFARM PI A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Finansielle holdingselskaber. The company was previously named ORIFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -446,000 and a net result of DKK 298,665,000 compared with DKK 320,939,000 the year before. Equity in the 2025 report amounted to DKK 1,391,995,000.
